샘플 요청 목록

 카트 문의
시장보고서
상품코드
1744865

Schmallenberg 바이러스 치료 시장

Schmallenberg Virus Treatment
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 378 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 Schmallenberg 바이러스 치료 시장은 2030년까지 1억 5,770만 달러에 달할 전망

2024년에 1억 940만 달러로 추정되는 세계의 Schmallenberg 바이러스 치료 시장은 2024-2030년에 CAGR 6.3%로 성장하며, 2030년에는 1억 5,770만 달러에 달할 것으로 예측됩니다. 이 리포트에서 분석되고 있는 부문의 하나인 소는 CAGR 5.0%를 기록하며, 분석 기간 종료시에는 7,530만 달러에 달할 것으로 예측됩니다. 양 부문의 성장률은 분석 기간에 CAGR 8.2%로 추정됩니다.

미국 시장은 2,980만 달러로 추정되는 세계의 한편, 중국은 CAGR 9.7%로 성장 예측

미국의 Schmallenberg 바이러스 치료 시장은 2024년에 2,980만 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 분석 기간인 2024-2030년에 CAGR 9.7%로 추이하며, 2030년에는 예측 시장 규모 3,200만 달러에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 3.2%와 6.1%로 예측됩니다. 유럽에서는 독일이 CAGR 4.1%로 성장할 것으로 예측됩니다.

세계의 Schmallenberg 바이러스 치료 시장 - 주요 동향과 촉진요인 정리

수의학계는 슈말렌베르크 바이러스의 조용한 위협에 어떻게 대처하고 있는가?

2011년 유럽에서 처음 확인된 슈말렌베르크 바이러스(SBV)는 주로 소, 양, 염소 등 반추동물에 감염되어 발열, 유량감소, 유산, 선천성 기형을 유발하는 신흥 전염병입니다. 이 전염병의 확산은 주로 물린 머릿니(문제)를 매개로 하는데, 특이적인 항바이러스 치료제가 없어 수의 보건 시스템에 어려움을 겪고 있습니다. 현재 시장 개발의 초점은 백신 개발과 조기 봉쇄를 위한 진단 프로토콜을 강화하는 두 가지입니다. 동물용 제약사들은 보다 광범위하고 지속적인 면역을 제공할 수 있는 불활화 백신과 재조합 백신의 연구개발을 강화하고 있습니다. 유럽, 아시아, 남미 각국의 정부 및 수의학 기관은 지역적 SBV 감시 프로그램, 바이오 보안 인식 제고, 규제 우대조치를 통한 백신 시험 신속화 등의 노력에 자금을 지원하고 있습니다. 시장 확대는 상업적 경작지에서의 가축 보호에 대한 수요 증가를 촉진하고 있습니다.

진단의 발전이 바이러스의 변이를 능가하는가?

검출과 진단은 슈말렌베르그 발병을 관리하는 데 있으며, 매우 중요한 요소로 작용하고 있습니다. 차세대 PCR 기반 검사, 혈청학적 ELISA 및 현장 진단이 개발되어 살아있는 동물과 태아 모두에서 검출 정확도가 향상되었습니다. 휴대용 분자 검사 키트는 특히 신흥 경제국에서 번식기나 분만 전 질병을 확인하기 위해 지방 동물병원에서 수요가 증가하고 있습니다. 날씨, 머릿니 이동, 가축 이동에 기반한 AI를 활용한 발생 예측 모델도 수의학 의사결정 지원 시스템에 통합되고 있습니다. 이러한 기술들은 비발생 지역에서의 예측할 수 없는 바이러스 재유행을 완화하고 낙농 및 육류 생산의 경제적 손실을 줄이는 데 도움이 되고 있습니다.

바이오 보안 정책과 세계 가축 무역의 역할은 무엇인가?

가축 무역의 세계화와 기후로 인한 매개동물의 확대는 국경을 초월한 SBV 전파의 위험을 높이는 매우 중요한 요소입니다. 따라서 질병 대책에 대한 국가 간 협력이 점점 더 중요해지고 있습니다. 수출 규제는 SBV에 감염되지 않은 것으로 입증된 소를 요구하고 있으며, 농장은 예방접종과 예방진단에 투자해야 합니다. 피해 지역 정부와 농무부는 가축 추적 시스템 및 바이오 보안 구역 설정을 의무화하여 질병 확산을 방지하고 있습니다. 또한 인수공통전염병과 신종 전염병에 대한 팬데믹 시대의 스포트라이트는 수의학 인프라에 대한 인식과 자금을 증가시켜 SBV 치료 시장에 간접적인 이익을 가져다주고 있습니다. 가축 보험사 및 농산업 이해관계자들도 책임을 최소화하기 위해 백신 채택을 추진하고 있습니다.

Schmallenberg 바이러스 치료 시장의 성장은 몇 가지 요인에 의해 촉진됩니다.

백신과 고감도 진단키트 등 예방책이 강조되고 있는 가운데 결정적인 치료법이 없습니다는 점이 시장 성장을 촉진하고 있습니다. 특히 유럽과 라틴아메리카에서는 상업적 축산업이 확대되고 가축 질병에 대한 경제적 부담이 커지면서 효과적인 SBV 대책에 대한 수요가 증가하고 있습니다. 동물용 백신 개발에 대한 규제 당국의 지원과 신속한 승인은 생명공학 기업이 SBV에 특화된 연구개발에 대한 투자를 촉진하고 있습니다. 기후 패턴의 변화로 인해 이 질병의 지역적 범위가 확대되어 치료와 방제를 위한 새로운 시장이 창출되고 있습니다. 통합 가축 관리 플랫폼의 부상, 수의학 예산 증가, 디지털 질병 모니터링 시스템은 슈말렌버그 바이러스 치료 솔루션의 긴급성과 상업적 실행 가능성을 총체적으로 강화하고 있습니다.

부문

동물 유형(소, 양, 염소, 기타 동물 유형); 치료 유형(항바이러스제, 항염증약, 진통제, 백신); 최종사용자(동물병원 & 클리닉, 조사기관, 동물 약국 & 드러그스토어, 기타 최종사용자)

조사 대상 기업의 예(총 36건)

  • Bayer Animal Health
  • Boehringer Ingelheim
  • Ceva Sante Animale
  • Dechra Pharmaceuticals
  • Elanco Animal Health
  • Heska Corporation
  • Huvepharma
  • IDEXX Laboratories
  • IDT Biologika
  • Merial(now part of Boehringer Ingelheim)
  • MSD Animal Health(Merck Animal Health)
  • Neogen Corporation
  • Phibro Animal Health
  • Vetoquinol
  • Virbac
  • Zoetis

관세 영향 계수

Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 인위적인 수입원가 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

Global Industry Analysts는 세계 주요 수석 이코노미스트(1,4,949명), 싱크탱크(62개 기관), 무역 및 산업 단체(171개 기관)의 전문가들의 의견을 면밀히 검토하여 생태계에 미치는 영향을 평가하고 새로운 시장 현실에 대응하고 있습니다. 모든 주요 국가의 전문가와 경제학자들이 관세와 그것이 자국에 미치는 영향에 대한 의견을 추적 조사했습니다.

Global Industry Analysts는 이러한 혼란이 향후 2-3개월 내에 마무리되고 새로운 세계 질서가 보다 명확하게 확립될 것으로 예상하고 있으며, Global Industry Analysts는 이러한 상황을 실시간으로 추적하고 있습니다.

2025년 4월: 협상 단계

이번 4월 보고서에서는 관세가 세계 시장 전체에 미치는 영향과 지역별 시장 조정에 대해 소개합니다. 당사의 예측은 과거 데이터와 진화하는 시장 영향요인을 기반으로 합니다.

2025년 7월: 최종 관세 재설정

고객님들께는 각 국가별 최종 리셋이 발표된 후 7월에 무료 업데이트 버전을 제공해 드립니다. 최종 업데이트 버전에는 명확하게 정의된 관세 영향 분석이 포함되어 있습니다.

상호 및 양자 간 무역과 관세의 영향 분석 :

미국 < gt; 중국 < gt; 멕시코 < gt; 캐나다 < gt; EU < gt; 일본 < gt; 인도 < gt; 기타 176개국

업계 최고의 이코노미스트: Global Industry Analysts의 지식 기반은 국가, 싱크탱크, 무역 및 산업 단체, 대기업, 그리고 세계 계량 경제 상황의 전례 없는 패러다임 전환의 영향을 공유하는 분야별 전문가 등 가장 영향력 있는 수석 이코노미스트 그룹을 포함한 14,949명의 이코노미스트를 추적하고 있습니다. 16,491개 이상의 보고서 대부분에 마일스톤에 기반한 2단계 출시 일정이 적용되어 있습니다.

목차

제1장 조사 방법

제2장 개요

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSA 25.06.23

Global Schmallenberg Virus Treatment Market to Reach US$157.7 Million by 2030

The global market for Schmallenberg Virus Treatment estimated at US$109.4 Million in the year 2024, is expected to reach US$157.7 Million by 2030, growing at a CAGR of 6.3% over the analysis period 2024-2030. Cattle, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$75.3 Million by the end of the analysis period. Growth in the Sheep segment is estimated at 8.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$29.8 Million While China is Forecast to Grow at 9.7% CAGR

The Schmallenberg Virus Treatment market in the U.S. is estimated at US$29.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$32.0 Million by the year 2030 trailing a CAGR of 9.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.2% and 6.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.1% CAGR.

Global Schmallenberg Virus Treatment Market - Key Trends & Drivers Summarized

How Is the Veterinary Sector Tackling the Silent Threat of Schmallenberg Virus?

First identified in Europe in 2011, Schmallenberg virus (SBV) is an emerging infectious disease that primarily affects ruminants-such as cattle, sheep, and goats-causing fever, reduced milk yield, abortions, and congenital deformities. While its spread is largely vector-borne via biting midges (Culicoides spp.), the lack of specific antiviral treatments has posed a challenge to veterinary health systems. The current focus in the market is twofold: developing vaccines and enhancing diagnostic protocols for early containment. Veterinary pharmaceutical firms are intensifying R&D on inactivated and recombinant vaccines that can provide broader and longer-lasting immunity. Governments and veterinary bodies across Europe, Asia, and South America are funding initiatives for regional SBV surveillance programs, biosecurity awareness, and fast-tracking vaccine trials through regulatory incentives. The market’s expansion is also aided by increasing demand for livestock protection in commercial farming zones.

Are Diagnostic Advancements Outpacing Viral Mutations?

Detection and diagnostics have emerged as crucial pillars in managing Schmallenberg outbreaks. New-generation PCR-based tests, serological ELISAs, and point-of-care diagnostics are being developed to improve detection accuracy in both live animals and fetuses. Portable molecular testing kits are seeing demand in rural veterinary clinics, especially in developing economies, to identify the disease before breeding or calving seasons. AI-powered outbreak prediction models based on weather, midge migration, and livestock movement are also being integrated into veterinary decision-support systems. These technologies are helping mitigate the unpredictable re-emergence of the virus in non-endemic areas, thus reducing economic losses in dairy and meat production.

What Role Do Biosecurity Policies and Global Livestock Trade Play?

The globalization of livestock trade and climate-driven vector expansion are pivotal factors increasing the risk of SBV transmission across borders. As such, cross-country coordination on disease control is becoming more vital. Export regulations now increasingly demand certified SBV-free herds, driving farms to invest in immunization and preventive diagnostics. Governments and agricultural ministries in affected regions have rolled out mandatory livestock tracking systems and biosecurity zoning to limit disease spread. Furthermore, the pandemic-era spotlight on zoonotic and emerging diseases has heightened awareness and funding for veterinary health infrastructure, indirectly benefiting the SBV treatment market. Herd insurance firms and agribusiness stakeholders are also pushing for vaccine adoption to minimize liability.

The Growth in the Schmallenberg Virus Treatment Market Is Driven by Several Factors

The market growth is propelled by the absence of a definitive cure, which emphasizes preventive measures such as vaccines and high-sensitivity diagnostic kits. Expansion of commercial livestock farming, especially in Europe and Latin America, has raised the financial stakes of livestock diseases, increasing demand for effective SBV countermeasures. Regulatory support for veterinary vaccine development and fast-track approvals are encouraging biotech companies to invest in SBV-specific R&D. Changing climate patterns are expanding the geographic range of the disease, creating new markets for treatment and control. The rise of integrated livestock management platforms, increased veterinary healthcare budgets, and digital disease monitoring systems are collectively reinforcing the urgency and commercial viability of Schmallenberg virus treatment solutions.

SCOPE OF STUDY:

The report analyzes the Schmallenberg Virus Treatment market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Animal Type (Cattle, Sheep, Goats, Other Animal Types); Treatment Type (Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics, Vaccines); End-Use (Veterinary Hospitals & Clinics, Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

  • Bayer Animal Health
  • Boehringer Ingelheim
  • Ceva Sante Animale
  • Dechra Pharmaceuticals
  • Elanco Animal Health
  • Heska Corporation
  • Huvepharma
  • IDEXX Laboratories
  • IDT Biologika
  • Merial (now part of Boehringer Ingelheim)
  • MSD Animal Health (Merck Animal Health)
  • Neogen Corporation
  • Phibro Animal Health
  • Vetoquinol
  • Virbac
  • Zoetis

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Schmallenberg Virus Treatment - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Schmallenberg Virus in Cattle and Sheep Drives Urgency for Therapeutic Development
    • Expansion of Livestock Disease Surveillance Programs Supports Early Detection and Response
    • Government Funding for Zoonotic Disease Research Accelerates Vaccine and Antiviral R&D
    • Growing Veterinary Awareness and Diagnostic Capabilities Strengthen Case for Targeted Treatments
    • Public Concern Over Animal Welfare and Agricultural Losses Spurs Market for Preventive Therapies
    • Academic and Industry Collaborations Enhance Virology Research and Treatment Innovation
    • Lack of Approved Therapeutics Presents White Space for Vaccine Developers and Biopharma Entrants
    • Integration of Schmallenberg Monitoring Into Broader Animal Health Platforms Improves Epidemiological Control
    • Import Restrictions and Trade Concerns Create Economic Incentives for Eradication Programs
    • Barriers in Funding, Commercial Viability, and Regulatory Pathways Challenge Treatment Launch Timelines
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Schmallenberg Virus Treatment Market Analysis of Annual Sales in US$ for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Schmallenberg Virus Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Schmallenberg Virus Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Cattle by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Cattle by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Cattle by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Sheep by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Sheep by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Sheep by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Goats by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Goats by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Goats by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Animal Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Animal Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Other Animal Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Research Institutions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Research Institutions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Research Institutions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Veterinary Pharmacies & Drug Store by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Veterinary Pharmacies & Drug Store by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Veterinary Pharmacies & Drug Store by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Veterinary Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Veterinary Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Veterinary Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Antiviral Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Antiviral Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Antiviral Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Anti-Inflammatory Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Anti-Inflammatory Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Anti-Inflammatory Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Analgesics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Analgesics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Analgesics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 40: World 15-Year Perspective for Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Schmallenberg Virus Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 41: USA Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Schmallenberg Virus Treatment by Animal Type - Percentage Breakdown of Value Sales for Cattle, Sheep, Goats and Other Animal Types for the Years 2015, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Schmallenberg Virus Treatment by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 49: USA 15-Year Perspective for Schmallenberg Virus Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Schmallenberg Virus Treatment by Animal Type - Percentage Breakdown of Value Sales for Cattle, Sheep, Goats and Other Animal Types for the Years 2015, 2025 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Schmallenberg Virus Treatment by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 58: Canada 15-Year Perspective for Schmallenberg Virus Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines for the Years 2015, 2025 & 2030
  • JAPAN
    • Schmallenberg Virus Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Schmallenberg Virus Treatment by Animal Type - Percentage Breakdown of Value Sales for Cattle, Sheep, Goats and Other Animal Types for the Years 2015, 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for Schmallenberg Virus Treatment by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 67: Japan 15-Year Perspective for Schmallenberg Virus Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines for the Years 2015, 2025 & 2030
  • CHINA
    • Schmallenberg Virus Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 68: China Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Schmallenberg Virus Treatment by Animal Type - Percentage Breakdown of Value Sales for Cattle, Sheep, Goats and Other Animal Types for the Years 2015, 2025 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 73: China 15-Year Perspective for Schmallenberg Virus Treatment by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 76: China 15-Year Perspective for Schmallenberg Virus Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines for the Years 2015, 2025 & 2030
  • EUROPE
    • Schmallenberg Virus Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Schmallenberg Virus Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Schmallenberg Virus Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Schmallenberg Virus Treatment by Animal Type - Percentage Breakdown of Value Sales for Cattle, Sheep, Goats and Other Animal Types for the Years 2015, 2025 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 85: Europe 15-Year Perspective for Schmallenberg Virus Treatment by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 88: Europe 15-Year Perspective for Schmallenberg Virus Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines for the Years 2015, 2025 & 2030
  • FRANCE
    • Schmallenberg Virus Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 89: France Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for Schmallenberg Virus Treatment by Animal Type - Percentage Breakdown of Value Sales for Cattle, Sheep, Goats and Other Animal Types for the Years 2015, 2025 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 94: France 15-Year Perspective for Schmallenberg Virus Treatment by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 95: France Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 96: France Historic Review for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 97: France 15-Year Perspective for Schmallenberg Virus Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines for the Years 2015, 2025 & 2030
  • GERMANY
    • Schmallenberg Virus Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for Schmallenberg Virus Treatment by Animal Type - Percentage Breakdown of Value Sales for Cattle, Sheep, Goats and Other Animal Types for the Years 2015, 2025 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 103: Germany 15-Year Perspective for Schmallenberg Virus Treatment by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 104: Germany Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Germany Historic Review for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 106: Germany 15-Year Perspective for Schmallenberg Virus Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for Schmallenberg Virus Treatment by Animal Type - Percentage Breakdown of Value Sales for Cattle, Sheep, Goats and Other Animal Types for the Years 2015, 2025 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 112: Italy 15-Year Perspective for Schmallenberg Virus Treatment by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 113: Italy Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Italy Historic Review for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 115: Italy 15-Year Perspective for Schmallenberg Virus Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Schmallenberg Virus Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 116: UK Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for Schmallenberg Virus Treatment by Animal Type - Percentage Breakdown of Value Sales for Cattle, Sheep, Goats and Other Animal Types for the Years 2015, 2025 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 121: UK 15-Year Perspective for Schmallenberg Virus Treatment by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 122: UK Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 123: UK Historic Review for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 124: UK 15-Year Perspective for Schmallenberg Virus Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 127: Spain 15-Year Perspective for Schmallenberg Virus Treatment by Animal Type - Percentage Breakdown of Value Sales for Cattle, Sheep, Goats and Other Animal Types for the Years 2015, 2025 & 2030
    • TABLE 128: Spain Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Spain Historic Review for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 130: Spain 15-Year Perspective for Schmallenberg Virus Treatment by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 131: Spain Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Spain Historic Review for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 133: Spain 15-Year Perspective for Schmallenberg Virus Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 136: Russia 15-Year Perspective for Schmallenberg Virus Treatment by Animal Type - Percentage Breakdown of Value Sales for Cattle, Sheep, Goats and Other Animal Types for the Years 2015, 2025 & 2030
    • TABLE 137: Russia Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Russia Historic Review for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 139: Russia 15-Year Perspective for Schmallenberg Virus Treatment by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 140: Russia Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Russia Historic Review for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 142: Russia 15-Year Perspective for Schmallenberg Virus Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of Europe 15-Year Perspective for Schmallenberg Virus Treatment by Animal Type - Percentage Breakdown of Value Sales for Cattle, Sheep, Goats and Other Animal Types for the Years 2015, 2025 & 2030
    • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of Europe Historic Review for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 148: Rest of Europe 15-Year Perspective for Schmallenberg Virus Treatment by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Rest of Europe Historic Review for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 151: Rest of Europe 15-Year Perspective for Schmallenberg Virus Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Schmallenberg Virus Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Schmallenberg Virus Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 15-Year Perspective for Schmallenberg Virus Treatment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 15-Year Perspective for Schmallenberg Virus Treatment by Animal Type - Percentage Breakdown of Value Sales for Cattle, Sheep, Goats and Other Animal Types for the Years 2015, 2025 & 2030
    • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Asia-Pacific Historic Review for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 160: Asia-Pacific 15-Year Perspective for Schmallenberg Virus Treatment by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Asia-Pacific Historic Review for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 163: Asia-Pacific 15-Year Perspective for Schmallenberg Virus Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Schmallenberg Virus Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 166: Australia 15-Year Perspective for Schmallenberg Virus Treatment by Animal Type - Percentage Breakdown of Value Sales for Cattle, Sheep, Goats and Other Animal Types for the Years 2015, 2025 & 2030
    • TABLE 167: Australia Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Australia Historic Review for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 169: Australia 15-Year Perspective for Schmallenberg Virus Treatment by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 170: Australia Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Australia Historic Review for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 172: Australia 15-Year Perspective for Schmallenberg Virus Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines for the Years 2015, 2025 & 2030
  • INDIA
    • Schmallenberg Virus Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 173: India Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 175: India 15-Year Perspective for Schmallenberg Virus Treatment by Animal Type - Percentage Breakdown of Value Sales for Cattle, Sheep, Goats and Other Animal Types for the Years 2015, 2025 & 2030
    • TABLE 176: India Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 177: India Historic Review for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 178: India 15-Year Perspective for Schmallenberg Virus Treatment by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 179: India Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 180: India Historic Review for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 181: India 15-Year Perspective for Schmallenberg Virus Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 184: South Korea 15-Year Perspective for Schmallenberg Virus Treatment by Animal Type - Percentage Breakdown of Value Sales for Cattle, Sheep, Goats and Other Animal Types for the Years 2015, 2025 & 2030
    • TABLE 185: South Korea Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 186: South Korea Historic Review for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 187: South Korea 15-Year Perspective for Schmallenberg Virus Treatment by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 188: South Korea Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 189: South Korea Historic Review for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 190: South Korea 15-Year Perspective for Schmallenberg Virus Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Schmallenberg Virus Treatment by Animal Type - Percentage Breakdown of Value Sales for Cattle, Sheep, Goats and Other Animal Types for the Years 2015, 2025 & 2030
    • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Asia-Pacific Historic Review for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 196: Rest of Asia-Pacific 15-Year Perspective for Schmallenberg Virus Treatment by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Asia-Pacific Historic Review for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Asia-Pacific 15-Year Perspective for Schmallenberg Virus Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Schmallenberg Virus Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Schmallenberg Virus Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 202: Latin America 15-Year Perspective for Schmallenberg Virus Treatment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 205: Latin America 15-Year Perspective for Schmallenberg Virus Treatment by Animal Type - Percentage Breakdown of Value Sales for Cattle, Sheep, Goats and Other Animal Types for the Years 2015, 2025 & 2030
    • TABLE 206: Latin America Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Latin America Historic Review for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 208: Latin America 15-Year Perspective for Schmallenberg Virus Treatment by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 209: Latin America Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Latin America Historic Review for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 211: Latin America 15-Year Perspective for Schmallenberg Virus Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 214: Argentina 15-Year Perspective for Schmallenberg Virus Treatment by Animal Type - Percentage Breakdown of Value Sales for Cattle, Sheep, Goats and Other Animal Types for the Years 2015, 2025 & 2030
    • TABLE 215: Argentina Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Argentina Historic Review for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 217: Argentina 15-Year Perspective for Schmallenberg Virus Treatment by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 218: Argentina Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Argentina Historic Review for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 220: Argentina 15-Year Perspective for Schmallenberg Virus Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 223: Brazil 15-Year Perspective for Schmallenberg Virus Treatment by Animal Type - Percentage Breakdown of Value Sales for Cattle, Sheep, Goats and Other Animal Types for the Years 2015, 2025 & 2030
    • TABLE 224: Brazil Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Brazil Historic Review for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 226: Brazil 15-Year Perspective for Schmallenberg Virus Treatment by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 227: Brazil Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Brazil Historic Review for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 229: Brazil 15-Year Perspective for Schmallenberg Virus Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 232: Mexico 15-Year Perspective for Schmallenberg Virus Treatment by Animal Type - Percentage Breakdown of Value Sales for Cattle, Sheep, Goats and Other Animal Types for the Years 2015, 2025 & 2030
    • TABLE 233: Mexico Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Mexico Historic Review for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 235: Mexico 15-Year Perspective for Schmallenberg Virus Treatment by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 236: Mexico Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Mexico Historic Review for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 238: Mexico 15-Year Perspective for Schmallenberg Virus Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 241: Rest of Latin America 15-Year Perspective for Schmallenberg Virus Treatment by Animal Type - Percentage Breakdown of Value Sales for Cattle, Sheep, Goats and Other Animal Types for the Years 2015, 2025 & 2030
    • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Rest of Latin America Historic Review for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 244: Rest of Latin America 15-Year Perspective for Schmallenberg Virus Treatment by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Rest of Latin America Historic Review for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 247: Rest of Latin America 15-Year Perspective for Schmallenberg Virus Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Schmallenberg Virus Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Schmallenberg Virus Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 250: Middle East 15-Year Perspective for Schmallenberg Virus Treatment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 253: Middle East 15-Year Perspective for Schmallenberg Virus Treatment by Animal Type - Percentage Breakdown of Value Sales for Cattle, Sheep, Goats and Other Animal Types for the Years 2015, 2025 & 2030
    • TABLE 254: Middle East Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Middle East Historic Review for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 256: Middle East 15-Year Perspective for Schmallenberg Virus Treatment by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 257: Middle East Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Middle East Historic Review for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 259: Middle East 15-Year Perspective for Schmallenberg Virus Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 262: Iran 15-Year Perspective for Schmallenberg Virus Treatment by Animal Type - Percentage Breakdown of Value Sales for Cattle, Sheep, Goats and Other Animal Types for the Years 2015, 2025 & 2030
    • TABLE 263: Iran Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Iran Historic Review for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 265: Iran 15-Year Perspective for Schmallenberg Virus Treatment by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 266: Iran Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Iran Historic Review for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 268: Iran 15-Year Perspective for Schmallenberg Virus Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 271: Israel 15-Year Perspective for Schmallenberg Virus Treatment by Animal Type - Percentage Breakdown of Value Sales for Cattle, Sheep, Goats and Other Animal Types for the Years 2015, 2025 & 2030
    • TABLE 272: Israel Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Israel Historic Review for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 274: Israel 15-Year Perspective for Schmallenberg Virus Treatment by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 275: Israel Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Israel Historic Review for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 277: Israel 15-Year Perspective for Schmallenberg Virus Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 280: Saudi Arabia 15-Year Perspective for Schmallenberg Virus Treatment by Animal Type - Percentage Breakdown of Value Sales for Cattle, Sheep, Goats and Other Animal Types for the Years 2015, 2025 & 2030
    • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Saudi Arabia Historic Review for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 283: Saudi Arabia 15-Year Perspective for Schmallenberg Virus Treatment by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Saudi Arabia Historic Review for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 286: Saudi Arabia 15-Year Perspective for Schmallenberg Virus Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 289: UAE 15-Year Perspective for Schmallenberg Virus Treatment by Animal Type - Percentage Breakdown of Value Sales for Cattle, Sheep, Goats and Other Animal Types for the Years 2015, 2025 & 2030
    • TABLE 290: UAE Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 291: UAE Historic Review for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 292: UAE 15-Year Perspective for Schmallenberg Virus Treatment by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 293: UAE Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 294: UAE Historic Review for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 295: UAE 15-Year Perspective for Schmallenberg Virus Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 298: Rest of Middle East 15-Year Perspective for Schmallenberg Virus Treatment by Animal Type - Percentage Breakdown of Value Sales for Cattle, Sheep, Goats and Other Animal Types for the Years 2015, 2025 & 2030
    • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Rest of Middle East Historic Review for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 301: Rest of Middle East 15-Year Perspective for Schmallenberg Virus Treatment by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Rest of Middle East Historic Review for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 304: Rest of Middle East 15-Year Perspective for Schmallenberg Virus Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines for the Years 2015, 2025 & 2030
  • AFRICA
    • Schmallenberg Virus Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 307: Africa 15-Year Perspective for Schmallenberg Virus Treatment by Animal Type - Percentage Breakdown of Value Sales for Cattle, Sheep, Goats and Other Animal Types for the Years 2015, 2025 & 2030
    • TABLE 308: Africa Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Africa Historic Review for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 310: Africa 15-Year Perspective for Schmallenberg Virus Treatment by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 311: Africa Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Africa Historic Review for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 313: Africa 15-Year Perspective for Schmallenberg Virus Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제